ARENA PHARMACEUTICALS INC's ticker is ARNAXXXX and the CUSIP is 040047102. A total of 120 filers reported holding ARENA PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 0.63 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $6,000,000 | -14.3% | 4,665 | -7.7% | 0.00% | +100.0% |
| Q4 2016 | $7,000,000 | +77677.8% | 5,054 | 0.0% | 0.00% | -50.0% |
| Q3 2016 | $9,000 | +12.5% | 5,054 | +6.3% | 0.00% | -33.3% |
| Q2 2016 | $8,000 | -20.0% | 4,754 | -9.5% | 0.00% | -25.0% |
| Q1 2016 | $10,000 | -23.1% | 5,254 | -27.6% | 0.00% | -20.0% |
| Q4 2015 | $13,000 | -43.5% | 7,254 | -40.8% | 0.01% | -37.5% |
| Q3 2015 | $23,000 | -62.9% | 12,254 | -8.9% | 0.01% | -61.9% |
| Q2 2015 | $62,000 | -3.1% | 13,454 | -8.2% | 0.02% | 0.0% |
| Q1 2015 | $64,000 | +4.9% | 14,654 | -17.0% | 0.02% | +5.0% |
| Q4 2014 | $61,000 | -17.6% | 17,654 | -0.3% | 0.02% | +33.3% |
| Q3 2014 | $74,000 | -14.0% | 17,704 | -10.2% | 0.02% | -66.7% |
| Q2 2014 | $86,000 | – | 19,704 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MANGROVE PARTNERS IM, LLC | 1,567,700 | $9,877,000 | 3.29% |
| Lyons Wealth Management, LLC. | 56,775 | $359,000 | 0.31% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,216,579 | $7,664,000 | 0.31% |
| Alpha Cubed Investments, LLC | 50,797 | $320,000 | 0.17% |
| SABBY MANAGEMENT, LLC | 215,700 | $1,359,000 | 0.08% |
| OppenheimerFunds, Inc. | 7,000,000 | $44,100,000 | 0.05% |
| PROFUND ADVISORS LLC | 181,051 | $1,141,000 | 0.05% |
| Brown Advisory Securities, LLC | 20,000 | $126,000 | 0.05% |
| WELLINGTON MANAGEMENT GROUP LLP | 27,549,128 | $173,561,000 | 0.05% |
| MURPHY CAPITAL MANAGEMENT INC | 45,000 | $283,000 | 0.05% |